Search research articles
Contact Us
Filters
Showing results (11-20 of 162) with videos related to
Page
of 17
Sort By:
Advances in Anatomic Pathology
|
February 10, 2015
Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates
James P Solomon, Donna E Hansel
Advances in Anatomic Pathology
|
June 25, 2009
Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder
Joshua F Coleman, Donna E Hansel
Surgical Pathology Clinics
|
November 28, 2015
Morphologic and Molecular Characteristics of Bladder Cancer
James P Solomon, Donna E Hansel
Expert Review of Anticancer Therapy
|
June 7, 2008
Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities
Donna E Hansel, Brian I Rini
Cancer Treatment Reviews
|
July 4, 2015
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma
Sadakatsu Ikeda, Donna E Hansel, Razelle Kurzrock
Histopathology
|
December 20, 2018
Non-urothelial carcinomas of the bladder
Sanghui Park, Victor E Reuter, Donna E Hansel
The American Journal of Surgical Pathology
|
August 2, 2008
Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder
Zhaoli Lane, Donna E Hansel, Jonathan I Epstein
The Urologic Clinics of North America
|
April 2, 2013
Diagnostically challenging cases: what are atypia and dysplasia?
Joseph Sanfrancesco, J Stephen Jones, Donna E Hansel
Annals of Diagnostic Pathology
|
May 18, 2010
Primary lymphoepithelioma-like carcinoma of the ureter
Daniela S Allende, Mihir Desai, Donna E Hansel
Cancers
|
March 25, 2022
Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
Jianya Huan, Petros Grivas, Jasmine Birch, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 162) with videos related to
Sort By:
Page
of 17
Advances in Anatomic Pathology
|
February 10, 2015
Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates
James P Solomon, Donna E Hansel
Advances in Anatomic Pathology
|
June 25, 2009
Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder
Joshua F Coleman, Donna E Hansel
Surgical Pathology Clinics
|
November 28, 2015
Morphologic and Molecular Characteristics of Bladder Cancer
James P Solomon, Donna E Hansel
Expert Review of Anticancer Therapy
|
June 7, 2008
Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities
Donna E Hansel, Brian I Rini
Cancer Treatment Reviews
|
July 4, 2015
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma
Sadakatsu Ikeda, Donna E Hansel, Razelle Kurzrock
Histopathology
|
December 20, 2018
Non-urothelial carcinomas of the bladder
Sanghui Park, Victor E Reuter, Donna E Hansel
The American Journal of Surgical Pathology
|
August 2, 2008
Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder
Zhaoli Lane, Donna E Hansel, Jonathan I Epstein
The Urologic Clinics of North America
|
April 2, 2013
Diagnostically challenging cases: what are atypia and dysplasia?
Joseph Sanfrancesco, J Stephen Jones, Donna E Hansel
Annals of Diagnostic Pathology
|
May 18, 2010
Primary lymphoepithelioma-like carcinoma of the ureter
Daniela S Allende, Mihir Desai, Donna E Hansel
Cancers
|
March 25, 2022
Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
Jianya Huan, Petros Grivas, Jasmine Birch, et al.
Page
of 17